Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000535547 | SCV000632901 | likely benign | Birt-Hogg-Dube syndrome | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000564648 | SCV000673413 | likely benign | Hereditary cancer-predisposing syndrome | 2020-11-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001584259 | SCV001819417 | likely benign | not provided | 2020-09-23 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000564648 | SCV002530166 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-09-03 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001584259 | SCV004219739 | likely benign | not provided | 2022-10-27 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003942772 | SCV004761327 | likely benign | FLCN-related condition | 2022-10-17 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |